Organon Pharma Indonesia Tbk. vs Sreeya Sewu Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sreeya Sewu Indonesia Tbk. trades at Rp915 (market cap 1.68T, 94.7K 24h volume). The key difference: Sreeya Sewu Indonesia Tbk. is far larger — about 16.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SIPD | |
|---|---|---|
Market Cap | 104.4B | 1.68T |
Volume | — | 94.7K |
Lot | — | 947 |
Turnover | — | 85.64M |
Average Price | — | 904.37 |
Value | — | 85.64M |
Indicative Equilibrium Price | — | 915 |
Indicative Equilibrium Volume | — | 3 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Sierad Produce Tbk (the Company) was established based on notarial deed No. 17 dated September 6, 1985 of Raden Santoso , notary in Jakarta and has been amenden based on the deed No. 27 dated April 16, 1986. PT. Sierad Produce is a chicken slaughterhouse and meat processing company founded in 1985. With four subsidiaries operating in the same line of business.
Read more on SIPD →